Drugs / Hydrolyzed Lignin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07246681 Comparator | Oct 2025 → Feb 2026 overdue | Helicobacter pylori infectious disease | Zagazig University | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydrolyzed Lignin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07246681 ↗ |